COVID vaccine: Bharat Biotech seeks DCGI emergency use authorisation for Covaxin MD Bureau8 Dec 2020 2:00 PM ISTCovaxin is an indigenous, inactivated vaccine being developed and maufactured at Bharat Biotech's Bio-Safety Level 3 bio containment facility.
Zydus Cadila gets DCGI nod for Phase 1 trial of novel molecule ZYIL1 Ruchika Sharma7 Dec 2020 2:22 PM ISTNew Delhi: Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical...
Pfizer seeks DCGI emergency use authorisation for COVID vaccine in India Ruchika Sharma7 Dec 2020 12:58 PM ISTNew Delhi: Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India (DCGI) an emergency use...
Covishield: Serum Institute seeks emergency use nod for first made in India COVID vaccine MD Bureau7 Dec 2020 12:35 PM ISTPoonawalla had said SII is in the process of submitting the data for the clinical trials to the DCGI and will seek emergency use authorization.
Clinical trial participants paid over Rs 12 crore compensation in last 3 years for adverse events: DCGI Ruchika Sharma6 Dec 2020 11:00 AM ISTAddressing a webinar, ''Regulatory Pathways for COVID19 Vaccines, Clinical trials, Rolling Reviews and Adverse Event Monitoring'', Drugs Controller...
COVID-19: Zydus Cadila gets DCGI nod to start phase 3 trials with Pegylated Interferon alpha-2b in India Ruchika Sharma5 Dec 2020 12:17 PM ISTPegylated Interferon alpha-2b,'PegiHep' is an approved drug and is being re-purposed for the treatment of COVID-19.
Serum Institute COVID vaccine shot, adverse reaction not related: DCGI finding MD Bureau3 Dec 2020 5:47 PM ISTThe DCGI arrived at the conclusion on Wednesday based on the recommendations of an independent expert committee which has also opined that...
Initial findings into Serum Institute 'adverse event' did not necessitate halting of trials: Govt Farhat Nasim2 Dec 2020 5:23 PM IST"We have been given to understand that there is a court case so we would not want to comment on the specifics of the case," Union Health Secretary...
Serum Institute plans Rs 100 crore case against Covishield Trial Participant who sought Rs 5 crore alleging serious side effect Farhat Nasim30 Nov 2020 3:21 PM ISTNew Delhi: Brewing controversy a man, who was administered 'Covishield' shots in a vaccine trial in Chennai alleged serious "neurological and...
Kiran Mazumdar-Shaw expects DCGI nod for Oxford Covid vaccine in emergency cases Ruchika Sharma25 Nov 2020 1:35 PM ISTNew Delhi: Biocon Executive Chairperson Kiran Mazumdar-Shaw on Tuesday said hopefully drugs regulator DCGI will give Emergency Use Authorization (EUA)...
Biological E begins phase I, II human trials of Covid vaccine Ruchika Sharma17 Nov 2020 1:55 PM ISTHyderabad: Biological E. Limited, a Hyderabad-based vaccines and pharmaceutical company, Dynavax Technologies Corporation , a US-based vaccine focused...
TataMD launches new diagnostic testing for COVID-19 Ruchika Sharma11 Nov 2020 12:20 PM ISTTataMD CHECK is a paper strip-based test with an image-based visual result readout.
